COVID-19 vaccination in individuals with inflammatory rheumatic diseases

Since the start of the SARS-CoV-2 vaccination campaign, our knowledge of the effects of vaccines in people with inflammatory rheumatic diseases has remained incomplete. In particular, the effects of immunomodulatory therapies on vaccine success are poorly understood. Three notable papers from the pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Skapenko, Alla, Schulze-Koops, Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Year in Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748886/
https://www.ncbi.nlm.nih.gov/pubmed/36517627
http://dx.doi.org/10.1038/s41584-022-00892-3
_version_ 1784849923332636672
author Skapenko, Alla
Schulze-Koops, Hendrik
author_facet Skapenko, Alla
Schulze-Koops, Hendrik
author_sort Skapenko, Alla
collection PubMed
description Since the start of the SARS-CoV-2 vaccination campaign, our knowledge of the effects of vaccines in people with inflammatory rheumatic diseases has remained incomplete. In particular, the effects of immunomodulatory therapies on vaccine success are poorly understood. Three notable papers from the past year have helped to fill these knowledge gaps.
format Online
Article
Text
id pubmed-9748886
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-97488862022-12-14 COVID-19 vaccination in individuals with inflammatory rheumatic diseases Skapenko, Alla Schulze-Koops, Hendrik Nat Rev Rheumatol Year in Review Since the start of the SARS-CoV-2 vaccination campaign, our knowledge of the effects of vaccines in people with inflammatory rheumatic diseases has remained incomplete. In particular, the effects of immunomodulatory therapies on vaccine success are poorly understood. Three notable papers from the past year have helped to fill these knowledge gaps. Nature Publishing Group UK 2022-12-14 2023 /pmc/articles/PMC9748886/ /pubmed/36517627 http://dx.doi.org/10.1038/s41584-022-00892-3 Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Year in Review
Skapenko, Alla
Schulze-Koops, Hendrik
COVID-19 vaccination in individuals with inflammatory rheumatic diseases
title COVID-19 vaccination in individuals with inflammatory rheumatic diseases
title_full COVID-19 vaccination in individuals with inflammatory rheumatic diseases
title_fullStr COVID-19 vaccination in individuals with inflammatory rheumatic diseases
title_full_unstemmed COVID-19 vaccination in individuals with inflammatory rheumatic diseases
title_short COVID-19 vaccination in individuals with inflammatory rheumatic diseases
title_sort covid-19 vaccination in individuals with inflammatory rheumatic diseases
topic Year in Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748886/
https://www.ncbi.nlm.nih.gov/pubmed/36517627
http://dx.doi.org/10.1038/s41584-022-00892-3
work_keys_str_mv AT skapenkoalla covid19vaccinationinindividualswithinflammatoryrheumaticdiseases
AT schulzekoopshendrik covid19vaccinationinindividualswithinflammatoryrheumaticdiseases

Ejemplares similares